4.7 Review

Mitochondrial Dysfunction: Cause or Consequence of Vascular Calcification?

Journal

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fcell.2021.611922

Keywords

mitochondria; VSMCs; calcification; mitophagy; oxidative phoshorylation

Funding

  1. Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J004316/1]
  2. Medical Research Council, UK [MC_UU_00018/2]

Ask authors/readers for more resources

Mitochondria play a crucial role in bioenergetics and biosynthesis within cells, but under oxidative stress, they can lead to dysfunction and cellular apoptosis, contributing to aging and inflammatory states. Maintaining mitochondrial homeostasis is essential for preserving the contractile phenotype of vascular smooth muscle cells, while mitochondrial dysfunction may directly contribute to vascular calcification and related pathologies.
Mitochondria are crucial bioenergetics powerhouses and biosynthetic hubs within cells, which can generate and sequester toxic reactive oxygen species (ROS) in response to oxidative stress. Oxidative stress-stimulated ROS production results in ATP depletion and the opening of mitochondrial permeability transition pores, leading to mitochondria dysfunction and cellular apoptosis. Mitochondrial loss of function is also a key driver in the acquisition of a senescence-associated secretory phenotype that drives senescent cells into a pro-inflammatory state. Maintaining mitochondrial homeostasis is crucial for retaining the contractile phenotype of the vascular smooth muscle cells (VSMCs), the most prominent cells of the vasculature. Loss of this contractile phenotype is associated with the loss of mitochondrial function and a metabolic shift to glycolysis. Emerging evidence suggests that mitochondrial dysfunction may play a direct role in vascular calcification and the underlying pathologies including (1) impairment of mitochondrial function by mineral dysregulation i.e., calcium and phosphate overload in patients with end-stage renal disease and (2) presence of increased ROS in patients with calcific aortic valve disease, atherosclerosis, type-II diabetes and chronic kidney disease. In this review, we discuss the cause and consequence of mitochondrial dysfunction in vascular calcification and underlying pathologies; the role of autophagy and mitophagy pathways in preventing mitochondrial dysfunction during vascular calcification and finally we discuss mitochondrial ROS, DRP1, and HIF-1 as potential novel markers and therapeutic targets for maintaining mitochondrial homeostasis in vascular calcification.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available